Purdue Sues Teva To Block 'Abuse-Proof' OxyContin Generic

Law360, New York (July 3, 2013, 3:50 PM EDT) -- Purdue Pharma LP hit Teva Pharmaceuticals USA Inc. with a suit in federal court in New York on Tuesday accusing Teva of patent infringement for seeking approval for a generic "abuse-proof" version of the painkiller OxyContin.

Purdue said Teva infringed by filing an abbreviated new drug application with the U.S. Food and Drug Administration seeking approval to manufacture and sell generic copies of the relatively new form of the medication before the expiration of the two patents covering the drug.

"The acts of infringement by Teva"...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.